At the 2024 Telstra Best of Business Awards in February, Earworx was recognised as the National Championing Health Award winner. Lisa Hellwege, the Clinical Director and Founder of Earworx, expressed her gratitude to the entire team and their patients for their trust and support. Earworx specialises in providing professional earwax removal services led by trained nurses using a procedure called microsuction.
Having identified a gap in the market for safe and gentle earwax removal services in her local community, Lisa started Earworx as a part-time venture alongside her role at the Royal Hobart Hospital. Over time, the business grew, and she transitioned to running it full-time, overcoming various challenges along the way, including the impact of COVID-19 and navigating the regulatory environment.
The recognition received at the Telstra Best of Business Award was a meaningful validation of Earworx’s efforts. It not only bolstered the business’s already strong reputation but also provided a boost to its branding, according to Hellwege.
Describing the rigorous application process, including extensive submissions and nerve-wracking presentations, Hellwege acknowledged that it provided invaluable insights into their own business.
Looking ahead, Earworx aims to raise awareness about the vital role of registered nurses in supporting the Australian healthcare system and addressing its challenges. The business plans to continue its mission of delivering high-quality, nurse-led earwax removal services while advocating for recognition and support from funding bodies.
-
Investigating use of dietary supplements for osteoarthritis
Osteoarthritis is a leading cause of disability affecting over 2 million Australians, according to Australian Institute of Health and Welfare report on Chronic musculoskeletal conditions (2024) and 595 million people globally, according to BD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990–2020. It represents a significant public health burden that diminishes quality of life among ageing populations.
-
WA and QLD RSV Immunisation programs show drops in infant hospitalisations
RSV is the number one cause of hospitalisation of Australian children under five years of age, according to the Immunisation Foundation of Australia (IFA). There are mounting concerns that Australians at greatest risk of severe Respiratory Syncytial Virus, or RSV will miss out on protection against the lung infection, with the Federal Government failing to commit to a national RSV immunisation program.
-
Improved access to technology needed for people with Type 2 Diabetes needing insulin
The National Diabetes Services Scheme (NDSS) provides subsidised products for diabetes management; however, disparities exist in access to technology between those with Type 1 and Type 2 diabetes. While continuous glucose monitoring (CGM) devices are subsidised for Type 1, they are not available for Type 2 diabetes. ADEA advocates for equitable access to these essential tools, emphasising that all individuals with diabetes deserve the resources necessary for optimal management and reduced risk of complications. Without such technologies, many are forced to rely on finger pricking, which can be inconvenient and unsafe in settings such as the workplace and in higher education.
